---
$id: https://graph.org.ai/products/commodity/51401553
$type: Product
source: UNSPSC
code: "51401553"
title: "Temazepam"
class: "51401500"
classTitle: "Tranquilizers and antimanic and antianxiety benzodiazepines"
family: "51400000"
familyTitle: "Tranquilizers and antimanic and antianxiety drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Temazepam

**UNSPSC Code**: 51401553
**Class**: [Tranquilizers and antimanic and antianxiety benzodiazepines](Tranquilizers and antimanic and antianxiety benzodiazepines.mdx)
**Family**: [Tranquilizers and antimanic and antianxiety drugs](../Tranquilizers and antimanic and antianxiety drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-anxiety agent, gaba modulator, hypnotic, and sedative with the molecular formula C16H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHB1QD2QSS, chemically known as 1,3-dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as temazepam, which bears US NIH Compound Identifier 5391. European Medicines Agency schedules Temazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10880MIG. The term TEMAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules temazepam in its Anatomical Therapeutic Chemical (ATC) Classification. TEMAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule temazepam under HS 29339190 and SITC 51577. As of Q4 2014, TEMAZEPAM remains the US FDA Preferred Term for this commodity. Temazepam bears US NLM identifiers UMLS ID C0039468 and NCI Concept Code C29488. SMILES: CLC1CC2C(N(C(=O)C(O)N=C2C2CCCCC2)C)CC1.

